Hong Li
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (15)
Year:
2026
Cardiometabolic risk factors (CRFs) during pregnancy are early indicators of maternal diseases, such as stroke and type 2 diabetes. The total number of CRFs typically takes the form of binomial counts that exhibit overdispersion and zero inflation due to correlations among the underlying CRFs. Motivated by an examination of spatiotemporal trends in five CRFs among pregnant women in the U.S. state of South Carolina during the COVID-19 pandemic, we developed a zero-inflated beta-binomial model within a spatiotemporal framework. This model combines a point mass at zero to account for zero inflation and a beta-binomial distribution to model the remaining CRF counts. Given the notable racial disparities in CRFs during pregnancy that vary across the state over time, we incorporate a spatially varying coefficient model to explore the complex relationships between CRFs and geographic and temporal disparities among non-Hispanic White and non-Hispanic Black women. For posterior inference, we developed an efficient hybrid Markov Chain Monte Carlo algorithm that relies on easily sampled Gibbs and Metropolis–Hastings steps. Our analysis of CRFs in South Carolina reveals that certain counties, such as Chesterfield and Clarendon, exhibit gaps in racial health disparities, making them prime candidates for community-level interventions aimed at reducing these disparities.
Year:
2025
Triple-negative breast cancer (TNBC) disproportionately affects younger Black women, who show more aggressive phenotypes and poorer outcomes than women of other racial identities. While the impact of socioenvironmental inequities within and beyond health systems is well documented, the genetic influence in TNBC-associated racial disparities remains elusive. Here, we report that cancer-free breast tissue from Black women expresses TRIM37 at a significantly higher level relative to White women. A reporter-based screen for regulatory variants identifies a non-coding risk variant rs57141087 in the 5’ gene upstream region of the TRIM37 locus with enhancer activity. Mechanistically, rs57141087 increases enhancer–promoter interactions through NRF1, resulting in stronger TRIM37 promoter activity. Phenotypically, high TRIM37 levels drive neoplastic transformations in immortalized breast epithelial cells. Finally, context-dependent TRIM37 expression reveals that early-stage TRIM37 levels affect the initiation and trajectory of breast cancer progression. Together, our results indicate a genotype-informed association of oncogenic TRIM37 with TNBC risk in Black women and implicate TRIM37 as a predictive biomarker to better identify patients at risk of aggressive TNBC.
Year:
2024
In a recent 12-week smoking cessation trial, varenicline tartrate failed to show significant improvements in enhancing end-of-treatment abstinence when compared with placebo among adolescents and young adults. The original analysis aimed to assess the average effect across the entire population using timeline followback methods, which typically involve overdispersed binomial counts. We instead propose to investigate treatment effect heterogeneity among latent classes of participants using a Bayesian beta-binomial piecewise linear growth mixture model specifically designed to address longitudinal overdispersed binomial responses. Within each class, we fit a piecewise linear beta-binomial mixed model with random changepoints for each study group to detect critical windows of treatment efficacy. Using this model, we can cluster subjects who share similar characteristics, estimate the class-specific mean abstinence trends for each study group, and quantify the treatment effect over time within each class. Our analysis identified two classes of subjects: one comprising high-abstinent individuals, typically young adults and light smokers, in which varenicline led to improved abstinence; and another comprising low-abstinent individuals for whom varenicline showed no discernible effect. These findings highlight the importance of tailoring varenicline to specific participant subgroups, thereby advancing precision medicine in smoking cessation studies.
Year:
2024
Importance Somatic variants in the RAS/MAPK pathway genes are commonly associated with melanocytic nevi and melanoma, whereas germline variants in these genes are associated with RASopathies, syndromes involving multiple organs, including the skin. Nevi counts may be higher in some RASopathies, but studies on features observed through dermoscopy are limited. Objective To determine the distinguishing dermoscopic features of melanocytic nevi and how the RAS pathway influences them by comparing nevi in patients with cardiofaciocutaneous syndrome (CFC) and Costello syndrome (CS). Design, Setting, and Participants In this prospective cohort study, patients with CFC and CS, 2 RASopathies caused by variants in the downstream and upstream components of the RAS/MAPK pathway, were recruited from the international CFC and CS family conferences. Some patients with CFC also elected to participate in a longitudinal follow-up study. Main Outcomes and Measures The main outcomes were dermoscopic features and, in the longitudinal follow-up study, nevi counts, which were recorded over time. Results A total of 39 patients, 16 with CFC and 23 with CS, were enrolled (overall cohort: 26 [66.7%] female; median [IQR] age, 13.0 [7.6-22.0] years). The 112 nevi overall frequently displayed an organized dermoscopic pattern (CFC, 61 [84.7%]; CS, 34 [85.0%]) rather than a disorganized pattern (CFC, 6 [8.3%]; CS, 1 [2.5%]). Of the organized nevi, homogenous brown was the most common pattern (CFC, 41 [67.2%]; CS, 22 [64.7%]), followed by reticular (CFC, 11 [18.0%]; CS, 7 [20.6%]) and globular (CFC, 9 [14.8%]; CS, 5 [14.7%]). Pigmented networks occurred in 12 nevi in CFC (16.7%) and 6 nevi in CS (15%; P > .99). Of these, 6 CFC-associated nevi (50%) and no CS-associated nevi had atypical networks ( P = .05). Six patients with CFC in the follow-up study developed significantly more nevi within 5 years (median [IQR] increase, 24.5 [10-120] nevi; P = .04). Conclusions and Relevance In this cohort study, the findings suggest that nevi in patients with CFC and CS commonly display organized homogenous brown dermoscopic patterns, and the number of nevi may significantly increase over time in those with CFC. A disorganized pattern and atypical networks may be more frequent in patients with CFC. Future studies are needed to determine the risk of melanoma in individuals with CFC or CS.
Year:
2024
Year:
2024
Spatial count data with an abundance of zeros arise commonly in disease mapping studies. Typically, these data are analyzed using zero‐inflated models, which comprise a mixture of a point mass at zero and an ordinary count distribution, such as the Poisson or negative binomial. However, due to their mixture representation, conventional zero‐inflated models are challenging to explain in practice because the parameter estimates have conditional latent‐class interpretations. As an alternative, several authors have proposed marginalized zero‐inflated models that simultaneously model the excess zeros and the marginal mean, leading to a parameterization that more closely aligns with ordinary count models. Motivated by a study examining predictors of COVID‐19 death rates, we develop a spatiotemporal marginalized zero‐inflated negative binomial model that directly models the marginal mean, thus extending marginalized zero‐inflated models to the spatial setting. To capture the spatiotemporal heterogeneity in the data, we introduce region‐level covariates, smooth temporal effects, and spatially correlated random effects to model both the excess zeros and the marginal mean. For estimation, we adopt a Bayesian approach that combines full‐conditional Gibbs sampling and Metropolis–Hastings steps. We investigate features of the model and use the model to identify key predictors of COVID‐19 deaths in the US state of Georgia during the 2021 calendar year.
Year:
2024
Dysphagia, a common result of other medical conditions, is caused by malfunctions in swallowing physiology resulting in difficulty eating and drinking. The Modified Barium Swallow Study (MBSS), the most commonly used diagnostic tool for evaluating dysphagia, can be assessed using the Modified Barium Swallow Impairment Profile (MBSImP™). The MBSImP assessment tool consists of a hierarchical grouped data structure with multiple domains, a set of components within each domain which characterize specific swallowing physiologies, and a set of tasks scored on a discrete scale within each component. We lack sophisticated approaches to extract patterns of physiologic swallowing impairment from the MBSImP task scores within a component while still recognizing the nested structure of components within a domain. We propose a Bayesian hierarchical profile regression model, which uses a Bayesian profile regression model in conjunction with a hierarchical Dirichlet process mixture model to (1) cluster subjects into impairment profile patterns while respecting the hierarchical grouped data structure of the MBSImP, and (2) simultaneously determine associations between latent profile cluster membership for all components and the outcome of dysphagia severity. We apply our approach to a cohort of patients referred for an MBSS and assessed using the MBSImP. Our research results can be used to inform appropriate intervention strategies, and provide tools for clinicians to make better multidimensional management and treatment decisions for patients with dysphagia.
Year:
2024
Purpose Analysis of circulating tumor DNA (ctDNA) in patients with metastatic prostate cancer (mPC) provides an opportunity to identify and monitor genomic alterations during a patient’s treatment course. We evaluated whether the presence of specific gene amplifications (GAs) and plasma copy number (PCN) alterations are associated with disease features. Methods This is a single-institution retrospective study of patients with mPC who underwent ctDNA profiling using Guardant360 ® (Guardant Health Inc.). This test identifies single nucleotide variants (SNVs) and GAs of select genes by next-generation sequencing. A total of 155 men with mPC were studied. Patients were stratified by GA status. The Kaplan-Meier method and multivariate cox regression models were used to estimate overall survival (OS) or failure-free survival (FFS) from either the date of GA detection or the initiation of systemic therapy. The chi-square test was used to evaluate associations between clinical factors and GAs. Results The presence of liver and/or lung metastases was associated with GAs of BRAF, CDK6, PI3KCA , and FGFR1 . Survival analyses were completed on a subset of 83 patients with metastatic castration-resistant prostate cancer (mCRPC). Median OS was improved in patients with 1 GA compared to patients with ≥2 GAs, whether determined from the date of initial GA(s) detection (14.9 mo vs. 8.9 mo) or date of therapy initiation nearest to GA detection (16.7 mo vs. 9.0 mo). Patients without GAs had not reached median OS. Patients with androgen receptor ( AR ) GA only were also found to have better median OS compared to patients with AR GA plus at least one other additional GA (19.3 mo vs. 8.9 mo). Patients with PIK3CA GA had significantly lower median OS compared to patients with GAs that did not have a PIK3CA GA (5.9 mo vs. 16.0 mo). In patients with AR and/or MYC GA(s), median OS improved in those with reduced AR or MYC PCN during therapy compared to those without such a reduction (25.1 mo vs. 15.9 mo). Conclusions The association of select GAs with survival provides an additional tool for assessing mCRPC prognosis and informing management. Serial monitoring of ctDNA GAs is also useful to guide prognosis and therapeutic response.
Year:
2024
Timeline followback (TLFB) is often used in addiction research to monitor recent substance use, such as the number of abstinent days in the past week. TLFB data usually take the form of binomial counts that exhibit overdispersion and zero inflation. Motivated by a 12‐week randomized trial evaluating the efficacy of varenicline tartrate for smoking cessation among adolescents, we propose a Bayesian zero‐inflated beta‐binomial model for the analysis of longitudinal, bounded TLFB data. The model comprises a mixture of a point mass that accounts for zero inflation and a beta‐binomial distribution for the number of days abstinent in the past week. Because treatment effects appear to level off during the study, we introduce random changepoints for each study group to reflect group‐specific changes in treatment efficacy over time. The model also includes fixed and random effects that capture group‐ and subject‐level slopes before and after the changepoints. Using the model, we can accurately estimate the mean trend for each study group, test whether the groups experience changepoints simultaneously, and identify critical windows of treatment efficacy. For posterior computation, we propose an efficient Markov chain Monte Carlo algorithm that relies on easily sampled Gibbs and Metropolis–Hastings steps. Our application shows that the varenicline group has a short‐term positive effect on abstinence that tapers off after week 9.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (13)
Victoria Findlay
Associate Professor with Tenure
Virginia Commonwealth University
Sanchita Bhatnagar
Associate Professor
University of California, Davis
Bethany Wolf
Professor
Medical University of South Carolina
Marc Dall'Era
Professor and Chair
university of california davis medical center
James O'Malley
Professor of Biostatistics
Dartmouth College Geisel School of Medicine
David Turner
Tenured Professor & Vice Chair of Research
Virginia Commonwealth University
Valentina Medici
Professor
University of California, Davis
Jogender Tushir-Singh
Associate Professor
University of California
Caitlyn Meinzer
Assistant Professor of Biostatistics
Medical University of South Carolina
Brian Neelon
-
Bradley Krisanits
Assistant Professor of Biomedical Sciences
Morehead State University
Elizabeth Hill
Professor, Biostatistics Shared Resource Director
Medical University of South Carolina
Alan Lombard
Assistant Professor
University of California, Davis
Make your next move.
Prepare your application
Review drafts before you send them.